SCHEMBL1871349

SCHEMBL1871349

NC(=O)Nc1cccc(-c2nc3ccccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 15/20 0.64
▸ EGFR P00533 9/20 0.64
▸ ERBB2 P04626 9/20 0.64
▸ LCK P06239 5/20 0.64
▸ KDR P35968 5/20 0.64
▸ MAP4K5 Q9Y4K4 5/20 0.64
▸ FGFR1 P11362 4/20 0.64
▸ TAOK1 Q7L7X3 4/20 0.64
▸ AURKB Q96GD4 4/20 0.64
▸ STK3 Q13188 4/20 0.64
▸ PTK2 Q05397 4/20 0.64
▸ PRKD3 O94806 3/20 0.64
▸ SYK P43405 3/20 0.64
▸ SLK Q9H2G2 3/20 0.64
▸ MAP3K20 Q9NYL2 3/20 0.64
▸ CSF1R P07333 3/20 0.64
▸ MAP4K4 O95819 3/20 0.64
▸ FYN P06241 3/20 0.64
▸ RET P07949 3/20 0.64
▸ MAP4K2 Q12851 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1789167 0.93 IGF1R (0.71) IGF1REGFRERBB2LCKKDR
SCHEMBL1788634 0.91 IGF1R (0.62) IGF1REGFRERBB2LCKKDR
SCHEMBL1789150 0.89 IGF1R (0.67) IGF1REGFRERBB2LCKKDR
SCHEMBL1791235 0.89 IGF1R (0.79) IGF1REGFRERBB2LCKKDR
SCHEMBL1790887 0.89 IGF1R (0.61) IGF1REGFRERBB2LCKKDR
SCHEMBL1787369 0.89 IGF1R (0.80) IGF1REGFRERBB2LCKKDR
SCHEMBL1791539 0.89 BRAF (0.70) IGF1REGFRERBB2LCKKDR
SCHEMBL1788491 0.88 IGF1R (0.61) IGF1REGFRERBB2LCKKDR
SCHEMBL1788930 0.88 PTK2 (0.62) IGF1REGFRERBB2LCKKDR
SCHEMBL1791811 0.88 IGF1R (0.66) IGF1REGFRERBB2LCKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496574-A1 IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION Abbott Laboratories (US) 2012-09-12 — — EP claimed
WO-2011053476-A1 IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION ABBOTT LABORATORIES (US) 2011-05-05 — — WO claimed
Send feedback